Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.18
Delayed Data
As of Jul 29
 0.00 / 0.00%
Today’s Change
2.65
Today|||52-Week Range
5.87
-20.70%
Year-to-Date

Today’s Trading

Previous close3.18
Today’s open3.18
Day’s range3.10 - 3.21
Volume185,630
Average volume (3 months)155,831
Market cap$134.9M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-12.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.55+17.86%
EIGREiger BioPharmaceuti...-0.56-2.80%
AQXPAquinox Pharmaceutic...+0.03+0.36%
CLCDCoLucid Pharmaceutic...-0.61-6.55%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts

Partner Offers

Search for Jobs